JPWO2020055931A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020055931A5
JPWO2020055931A5 JP2021513327A JP2021513327A JPWO2020055931A5 JP WO2020055931 A5 JPWO2020055931 A5 JP WO2020055931A5 JP 2021513327 A JP2021513327 A JP 2021513327A JP 2021513327 A JP2021513327 A JP 2021513327A JP WO2020055931 A5 JPWO2020055931 A5 JP WO2020055931A5
Authority
JP
Japan
Prior art keywords
peptides
amino acids
library
apcs
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021513327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500034A5 (https=
JP2022500034A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/050492 external-priority patent/WO2020055931A1/en
Publication of JP2022500034A publication Critical patent/JP2022500034A/ja
Publication of JP2022500034A5 publication Critical patent/JP2022500034A5/ja
Publication of JPWO2020055931A5 publication Critical patent/JPWO2020055931A5/ja
Withdrawn legal-status Critical Current

Links

JP2021513327A 2018-09-10 2019-09-10 抗原特異的ｔリンパ球ならびに抗原特異的ｔリンパ球を作製および使用する方法 Withdrawn JP2022500034A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862729220P 2018-09-10 2018-09-10
US62/729,220 2018-09-10
US201962884527P 2019-08-08 2019-08-08
US62/884,527 2019-08-08
PCT/US2019/050492 WO2020055931A1 (en) 2018-09-10 2019-09-10 Antigen-specific t lymphocytes and methods of making and using the same

Publications (3)

Publication Number Publication Date
JP2022500034A JP2022500034A (ja) 2022-01-04
JP2022500034A5 JP2022500034A5 (https=) 2022-09-21
JPWO2020055931A5 true JPWO2020055931A5 (https=) 2022-09-21

Family

ID=69778456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021513327A Withdrawn JP2022500034A (ja) 2018-09-10 2019-09-10 抗原特異的ｔリンパ球ならびに抗原特異的ｔリンパ球を作製および使用する方法

Country Status (7)

Country Link
US (1) US20220033766A1 (https=)
EP (1) EP3849569A4 (https=)
JP (1) JP2022500034A (https=)
AU (1) AU2019339332A1 (https=)
CA (1) CA3112471A1 (https=)
IL (1) IL281339A (https=)
WO (1) WO2020055931A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190902A1 (en) * 2020-05-29 2023-06-22 Children's National Medical Center Identification of hla-restricted prame peptide epitopes, prame-specific t cells suitable for "off-the-shelf" treatment of cancer expressing prame
US20260041747A1 (en) 2022-07-29 2026-02-12 Repertoire Immune Medicines, Inc. T cell epitopes associated with type 1 diabetes
EP4605422A2 (en) 2022-10-20 2025-08-27 Repertoire Immune Medicines, Inc. Cd8 t cell targeted il2
WO2025072849A1 (en) 2023-09-29 2025-04-03 Repertoire Immune Medicines, Inc. Mhc-presentable peptides associated with type 1 diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007017201A1 (en) * 2005-08-05 2007-02-15 Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh Generation of antigen specific t cells
ES2635335T3 (es) * 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
WO2012112689A1 (en) 2011-02-15 2012-08-23 The University Of North Carolina At Chapel Hill Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers
EP3049114B1 (en) 2013-09-27 2021-11-10 Massachusetts Institute of Technology Carrier-free biologically-active protein nanostructures
EP3169352A1 (en) * 2014-07-15 2017-05-24 Immune Design Corp. Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
CN108990413A (zh) 2015-08-12 2018-12-11 麻省理工学院 纳米颗粒的细胞表面偶联

Similar Documents

Publication Publication Date Title
Den Haan et al. CD8+ but not CD8− dendritic cells cross-prime cytotoxic T cells in vivo
JP5127224B2 (ja) 予防又は治療目的のためのｍｈｃクラスｉ拘束性エピトープに対する免疫応答を誘発し、増強し、維持する方法
Steinman et al. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies
Ahlers et al. High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection
JP6230208B2 (ja) 樹状細胞／腫瘍細胞融合物および抗ｃｄ３／ｃｄ２８を使用する抗腫瘍免疫の刺激
Silk et al. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell–mediated immunotherapy
JP2022500034A5 (https=)
CN100337686C (zh) 从前体产生加载有抗原的树突细胞疫苗的快速一步法
Kim et al. Dendritic cells infected with poxvin vitro iruses encoding MART-1/Melan A sensitize T lymphocytes in vitro
NL2009102C2 (en) Method for dc-loading.
JP2011504101A5 (https=)
AU2008303453B2 (en) An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
CA2348956A1 (en) Immunotherapeutic methods using epitopes of wt-1 and gata-1
Dhodapkar et al. Active immunization of humans with dendritic cells
WO1998033527A2 (en) Cancer immunotherapy with semi-allogeneic cells
MXPA03007503A (es) Un metodo de terapia de celulas para el tratamiento de tumores.
CN1353575A (zh) 用树状细胞一肿瘤细胞或树状细胞一病毒细胞衍生的免疫原在体外诱导抗原特异性t－销细胞
Tirapu et al. Cytokine gene transfer into dendritic cells for cancer treatment
EP1509244B1 (en) New method and composition for producing a cellular allogeneic vaccine
Reichardt et al. Dendritic cells in vaccination therapies of human malignant disease
US7837990B2 (en) In vivo expanded NKT cells and methods of use thereof
US20090175890A1 (en) Use of immature dendritic cells to silence antigen specific cd8+ t cell function
JPWO2020055931A5 (https=)
Cohen et al. Use of interleukin-7, interleukin-2, and interferon-γ to propagate CD4+ T cells in culture with maintained antigen specificity
US20240252644A1 (en) Person-tailored t cell composition targeting merkel cell carcinoma